Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients
Conclusion: Our study suggests that telomere length in cfDNA may be a useful biomarker for predicting therapy response and possible reoccurrence of the disease in breast cancer patients.
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley
2024-01-01
|
| Reeks: | International Journal of Breast Cancer |
| Online toegang: | http://dx.doi.org/10.1155/2024/6117394 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|